Molecular targeted therapy in the treatment of gastric cancer        LIU Kun,LI Guo-li.Nanjing General Hospital of Nanjing Military Command, Army of General Surgery Institute of PLA, Nanjing 210002,China
Corresponding  author：LI Guo-li，E-mail：drguoli@yahoo.com.cn
Abstract    Gastric cancer is the most common malignant tumor of the digestive system in our country, and its fatality rate is the first in the malignant tumor. Since most patients had been in a period of progress when they were treated ,traditional surgery, radiotherapy and chemotherapy got a poor prognosis. Targeted therapy was hot in the field of cancer treatment , with highly effective and low toxic in the stomach cancer treatment. Targeted drugs in the gastric cancer includes: （1）the  ErbB passage targeted therapy; (2)VEGF and receivers for the order;(3) cells cycle modifier and the apoptosis cells of the reactants； (4) targeted therapy by EpCAM and porcine IGF1R .